Screening of New Tumor Drug Targets

A tumor refers to an abnormal lesion formed by a clonal abnormal proliferation of a certain cell in a local tissue under the action of various carcinogenic factors, which loses normal growth regulation at the gene level. In academia, tumors are generally divided into two categories: benign tumors and malignant tumors.

Based on TCGA, GEO big data or Creative Proteomics database or customer samples, we analyze and verify new functional genes that have not been reported to be functional or clinically relevant in the tumors studied, and to screen for new genes that have not been reported to be clinically relevant in the tumors studied. Genes, and various experimental verifications of the selected new functional genes at the cellular, in vivo level, and molecular mechanisms provide a preliminary data basis for the determination of targets and biomarkers for subsequent antitumor drugs. Creative Proteomics is committed to helping you explore and unravel the complexity of cancer. We know that the next major breakthrough in cancer will begin with research. This research started with you.

Screening of New Tumor Drug Targets

Our Advantage

Mature and reliable Genecard Total Solutions platform: rich project experience, participate in major projects, and publish high-level cooperation results.

The analysis contents and methods based on high-quality data analysis, pre-research and verification are indeed mature and feasible.

Please contact us to find out how we can help you achieve the next research breakthrough.

Learn More

* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Related Services:

  • Verification Code

CONTACT US

GET IN TOUCH

Copyright © 2021 Creative Proteomics. All Rights Reserved.